{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:10:17Z","timestamp":1773285017798,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.mehy.2014.03.007","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T05:06:08Z","timestamp":1395119168000},"page":"700-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Next target of tranilast: Inhibition of corneal neovascularization"],"prefix":"10.1016","volume":"82","author":[{"given":"Amir Hossein","family":"Norooznezhad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Norooznezhad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimia","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2014.03.007_b0005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00003226-198706040-00004","article-title":"Corneal neovascularization. Pathogenesis and inhibition","volume":"6","author":"Epstein","year":"1987","journal-title":"Cornea"},{"key":"10.1016\/j.mehy.2014.03.007_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2006.09.002","article-title":"Ocular neovascularization: implication of endogenous angiogenic inhibitors and potential therapy","volume":"26","author":"Zhang","year":"2007","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.mehy.2014.03.007_b0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/187221309789257450","article-title":"Corneal neovascularization: molecular events and therapeutic options","volume":"3","author":"Shakiba","year":"2009","journal-title":"Recent Pat Inflammation Allergy Drug Discovery"},{"key":"10.1016\/j.mehy.2014.03.007_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10456-008-9092-6","article-title":"Judah Folkman, a pioneer in the study of angiogenesis","volume":"11","author":"Ribatti","year":"2008","journal-title":"Angiogenesis"},{"key":"10.1016\/j.mehy.2014.03.007_b0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.vph.2006.01.005","article-title":"Angiogenesis, a new target for future therapy","volume":"44","author":"Pandya","year":"2006","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.mehy.2014.03.007_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.med.57.121304.131306","article-title":"Angiogenesis","volume":"57","author":"Folkman","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.mehy.2014.03.007_b0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/10273360410001700843","article-title":"Tumor-induced angiogenesis","volume":"5","author":"Plank","year":"2004","journal-title":"J Theor Med"},{"key":"10.1016\/j.mehy.2014.03.007_b0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/gb-2005-6-2-209","article-title":"The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease","volume":"6","author":"Holmes","year":"2005","journal-title":"Genome Biol"},{"key":"10.1016\/j.mehy.2014.03.007_b0045","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1357-2725(01)00027-9","article-title":"Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D","volume":"33","author":"Li","year":"2001","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.mehy.2014.03.007_b0050","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1242\/jcs.114.5.853","article-title":"The splice variants of vascular endothelial growth factor (VEGF) and their receptors","volume":"114","author":"Robinson","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1016\/j.mehy.2014.03.007_b0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/gb-2005-6-2-209","article-title":"The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease","volume":"6","author":"Holmes","year":"2005","journal-title":"Genome Biol"},{"key":"10.1016\/j.mehy.2014.03.007_b0060","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.mehy.2014.03.007_b0065","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.mehy.2014.03.007_b0070","first-page":"955","article-title":"Expression of integrins and MMPs during alkaline-burn-induced corneal angiogenesis","volume":"43","author":"Zhang","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.mehy.2014.03.007_b0075","first-page":"913","article-title":"Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing","volume":"39","author":"Ye","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.mehy.2014.03.007_b0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.exer.2004.08.023","article-title":"Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice","volume":"802","author":"Samolov","year":"2005","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.mehy.2014.03.007_b0085","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1167\/iovs.03-0249","article-title":"Reduced retinal angiogenesis in MMP-2 \u2013 deficient mice","volume":"44","author":"Ohno-Matsui","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.mehy.2014.03.007_b0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1167\/iovs.02-0180","article-title":"Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice","volume":"441","author":"Berglin","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.mehy.2014.03.007_b0095","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"issue":"9","key":"10.1016\/j.mehy.2014.03.007_b0100","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1172\/JCI6869","article-title":"The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development","volume":"103","author":"Eliceiri","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2014.03.007_b0105","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0002-9440(10)64643-3","article-title":"CD 18 and ICAM-1 dependent corneal neovascularization and inflammation after limbal injury","volume":"157","author":"Moromizato","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2014.03.007_b0110","first-page":"1427","article-title":"Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization","volume":"40","author":"Zhu","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.mehy.2014.03.007_b0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/08820538.2011.588652","article-title":"Inflammatory corneal neovascularization: etiopathogenesis","volume":"26","author":"Clements","year":"2011","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.mehy.2014.03.007_b0120","first-page":"330","article-title":"Comparison of topical interleukin-1 vs. tumor necrosis factor alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization and transplant survival (an American Ophthalmological Society thesis)","volume":"105","author":"Dana","year":"2007","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.mehy.2014.03.007_b0125","first-page":"2795","article-title":"Proinflammatory chemokine induction in keratocytes and inflammatory cell infiltration into the cornea","volume":"42","author":"Hong","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.mehy.2014.03.007_b0130","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1128\/IAI.58.8.2429-2437.1990","article-title":"Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance","volume":"58","author":"Henricson","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.mehy.2014.03.007_b0135","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1076\/ceyr.19.4.300.5301","article-title":"The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat","volume":"19","author":"Yamada","year":"1999","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.mehy.2014.03.007_b0140","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.bjp.0701493","article-title":"Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo","volume":"122","author":"Isaji","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2014.03.007_b0145","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.bjp.0702564","article-title":"Tranilast inhibits protein kinase C-dependent signaling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells","volume":"127","author":"Koyama","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2014.03.007_b0150","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0021-9150(97)00275-X","article-title":"Inhibitory effects of tranilast on expression of transforming growth factor-b isoforms and receptors in injured arteries","volume":"137","author":"Ward","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mehy.2014.03.007_b0155","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1167\/iovs.09-4161","article-title":"Inhibition by tranilast of the cytokine-induced expression of chemokines and the adhesion molecule VCAM-1 in human corneal fibroblasts","volume":"51","author":"Adachi","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.mehy.2014.03.007_b0160","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1124\/mol.62.4.856","article-title":"Tranilast inhibits cytokine-induced nuclear factor k\u03b2 activation in vascular endothelial cells","volume":"62","author":"Spiecker","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.mehy.2014.03.007_b0165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1155\/MI.2005.150","article-title":"Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro","volume":"2005","author":"Shimizu","year":"2005","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.mehy.2014.03.007_b0170","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1211\/jpp.58.1.0011","article-title":"Effect of tranilast on matrix metalloproteinase production from neutrophils in vitro","volume":"58","author":"Shimizu","year":"2006","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.mehy.2014.03.007_b0175","first-page":"459","article-title":"Suppression of laser-induced choroidal neovascularization by oral tranilast in the rat","volume":"40","author":"Takehana","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.mehy.2014.03.007_b0180","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbrc.2008.04.054","article-title":"Tranilast, an orally active anti-allergic drug, up-regulates the anti-inflammatory heme oxygenase-1 expression but down-regulates the pro-inflammatory cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW264.7 macrophages","volume":"371","author":"Pae","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2014.03.007_b0185","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1254\/jjp.60.85","article-title":"Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages","volume":"60","author":"Suzawa","year":"1992","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.mehy.2014.03.007_b0190","first-page":"2471","article-title":"Therapeutic potential of tranilast, an anti-allergy drug, in proliferative disorders","volume":"32","author":"Rogosnitzky","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.mehy.2014.03.007_b0195","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.jcrs.2007.07.041","article-title":"Safety and efficacy of intracapsular tranilast microspheres in experimental posterior capsule opacification","volume":"33","author":"Wang","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.mehy.2014.03.007_b0200","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00061198-200204000-00008","article-title":"Effects of tranilast on filtering blebs: a pilot study","volume":"11","author":"Etsuo","year":"2002","journal-title":"J Glaucoma"},{"key":"10.1016\/j.mehy.2014.03.007_b0205","first-page":"120","article-title":"A case in which tranilast ophthalmic solution was thought to be effective for the prevention of symblepharon and recurrence after pterygium surgery","volume":"36","author":"Tsuji","year":"2011","journal-title":"Tokai J Exp Clin Med"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714001091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714001091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T03:02:10Z","timestamp":1648609330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987714001091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0306987714001091"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2014.03.007","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next target of tranilast: Inhibition of corneal neovascularization","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2014.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}